Endoglin as a target of antitumor therapy

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Blood vascular supply significantly affects progression of tumor growth. Inhibition of endothelial cell proliferation by antiangiogenic drugs should lead to growth arrest of both primary tumors and metastases. During the course of lengthy therapy, endothelial cells may, however, become refractory to the action of antiangiogenic agents. Novel approaches to anticancer treatment should explore the issue of drug resistance shown by endothelial cells. One possible therapeutic solution might be tumor immunotherapy directed against antigens expressed on the surface of endothelial cells which co-form tumor blood vasculature. Such therapy is supposed to break immune tolerance to own antigens and to eliminate tumor blood vessel endothelial cells by activating cytotoxic T lymphocytes. This kind of response can be obtained against endoglin (CD105). Endoglin is overexpressed in proliferating endothelial cells which line tumor blood vessels. Presence of endoglin in solid tumor blood vessels has prognostic value in cancer treatment. CD105 is also expressed by certain cancer cells (prostate, melanoma and Ewing sarcoma). It appears that therapeutic strategies directed against endoglin allow several mechanisms of resistance to antiangiogenic drugs to be omitted. The therapeutic approach that we propose, i.e. a tumor blood vessel-destroying strategy combined with immunotherapy, may become an effective therapeutic tool.

Authors and Affiliations

Magdalena Jarosz, Stanisław Szala

Keywords

Related Articles

Cinacalcet therapy and cardiovascular risk in hemodialysis patients

Patients with end-stage kidney disease are at high cardiovascular risk due to accelerated atherosclerosis development. Important factors that accelerate the development of atherosclerosis in this group are calcium-phosp...

Mobile antibiotic resistance – the spread of genes determining the resistance of bacteria through food products

In recent years, more and more antibiotics have become ineffective in the treatment of bacterial nfections. The acquisition of antibiotic resistance by bacteria is associated with circulation of genes in the environment....

Epidemiologia Yersinia enterocolitica ze szczególnym uwzględnieniem rezerwuaru zwierzęcego

Do rodzaju Yersinia należą Gram–ujemne pałeczki obejmujące obecnie 18 gatunków. Yersinia enterocolitica to psychotrofowa pałeczka, która jest patogenem posiadającym wiele czynników wirulencji umożliwiających zarówno adhe...

Autofagia w niedokrwieniu mózgu

Autofagia jest wewnątrzkomórkowym procesem degradacji makrocząsteczek i organelli komórkowych odgrywającym ważną rolę w utrzymaniu homeostazy oraz odpowiedzi na wiele bodźców uszkadzających. W ciągu ostatnich kilku lat p...

Download PDF file
  • EP ID EP66861
  • DOI -
  • Views 162
  • Downloads 0

How To Cite

Magdalena Jarosz, Stanisław Szala (2013). Endoglin as a target of antitumor therapy . Advances in Hygiene and Experimental Medicine, 67(0), 79-89. https://europub.co.uk/articles/-A-66861